Acellular and Prokaryotic Microbes

Cards (99)

  • the smallest infectious agent (about 20nm - 300nm in diameter) and contain only one type of nucleic acid.

    Virus
  • infectious virus particle
    virion
  • Protein shell which surrounds and protects the genome. It is built up of multiple
    (identical) protein sub-units called capsomers.

    capsid
  • genome + capsid
    nucleocapsid
  • Lipoprotein membrane which surrounds some viruses, derived from the plasma membrane of the host cell

    Envelope
  • Proteins found in the envelope of the virion; usually glycosylated
    Glycoproteins
  • MORPHOLOGY
    Seen in many filamentous and pleomorphic viruses
    helical morphology
  • MORPHOLOGY
    Is characterized of many "spherical" viruses

    icosahedral morphology
  • polyhedron having 20 faces
    isocahedral
  • single molecule of nucleic acid
    monopartite genomes
  • places viruses into one of seven groups depending on a combination of their nucleic acid (DNA or RNA), strandedness (single-stranded or double-stranded), Sense, and method of replication.
    classification
  • adenoviruses, herpesviruses and poxviruses
    dsDNA viruses
  • parvoviruses

    ssDNA viruses
  • reoviruses
    dsRNA viruses
  • picornaviruses, togaviruses

    (+)ssRNA viruses
  • orthomyxoviruses, rhabdoviruses
    (-) ssRNA viruses
  • retroviruses

    ssRNA-RT viruses
  • hepadnaviruses
    dsDNA-RT viruses
  • Viruses originated in the primordial soup and coevolved with bacteria and archaea

    Coevolution theory
  • Viruses evolved from free-living prokaryotes that invaded other living organisms
    Retrograde Evolution Theory
  • Viruses are pieces of host cell RNA or DNA that have escaped from living cells and are no longer under cellular control
    Escaped Gene Theory
  • 3 types of origin of viruses theories
    coevolution theory, retrograde evolution theory, escaped gene theory
    • also known as adsorption
    • highly specific
    • The surface of the virion contains structures that interact receptors on the surface of the host cell.
    • It defines and limits the host species and type of cell that can be infected by a particular virus
    attachment
  • the process whereby the virion enters the cell
    penetration
    • the protein coat of the virion dissociates
    • the viral genome is released into the cytoplasm
    uncoating
  • 3 phases of biosynthesis
    early phase, genome replication, and late phase
  • Transcription of viral mRNA and translation of a number of non-structural proteins takes place
    early phase
  • Multiple copies of the viral genome are synthesized by a viral polymerase
    genome replication
  • Transcription and translation of viral mRNA and synthesis of the structural “late” proteins which are needed to make new virions
    late phase
    • the protein self-assemble and a genome enters each new capsid
    • this takes place either in the nucleus or in the cytoplasm of the cell, or sometimes, just beneath the cell surface
    assembly
  • the final stage of replication
    release
    1. implantation of virus at the portal of entry
    2. local replication
    3. spread to target organs (disease sites)
    4. spread to sites of shedding of virus into the environment
    pathogenic mechanisms of viral disease
  • A number of “entry-inhibiting” or “entry-blocking”
    drugs are being developed to fight HIV
    entry inhibitor
  • Amantadine and rimantadine, have been
    introduced to combat influenza
    • These agents act on penetration/uncoating
    uncoating inhibitor
  • By developing nucleotide or nucleoside analogues and deactivate the enzymes that synthesize the RNA or DNA once the analogue is incorporated
    reverse transcription
  • Splices the synthesized DNA into the host cell genome
    integrase
  • block attachment of transcription factors to viral DNA
    transcription
  • Based on “antisense” molecules or ribozyme antivirals that have been developed to treat HIV infections
    translation
  • it is used to treat selected patients with HIV infection
    protease inhibitors
  • Two drugs zanamivir (Relenza) and oseltamivir (Tamiflu) that have been introduced to treat influenza
    release phase